HyperRab (Rabies Immune Globulin-Human) (SD Viral Inactivated) Drug Interactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Drug Interactions

Repeated doses of HyperRab (Rabies Immune Globulin-Human) (SD Viral Inactivated) should not be administered once vaccine treatment has been initiated as this could prevent the full expression of active immunity expected from the rabies vaccine.
Other antibodies in the HyperRab (Rabies Immune Globulin-Human) (SD Viral Inactivated) preparation may interfere with the response to live vaccines eg, measles, mumps, polio or rubella. Therefore, immunization with live vaccines should not be given within 3 months after HyperRab (Rabies Immune Globulin-Human) (SD Viral Inactivated) administration.

HyperRab (Rabies Immune Globulin-Human) (SD Viral Inactivated) Drug Interactions

rabies immunoglobulin

Manufacturer:

Grifols

Distributor:

Luen Cheong Hong